Nureca Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Nureca şirketinin kazançları yıllık ortalama -68.2% oranında azalırken, Medical Equipment sektörünün kazançları yıllık 17.6% oranında artan oldu. Gelirler yıllık ortalama 42.3% oranında azalan oldu.

Anahtar bilgiler

-68.2%

Kazanç büyüme oranı

-71.3%

EPS büyüme oranı

Medical Equipment Sektör Büyümesi	23.0%
Gelir büyüme oranı	-42.3%
Özkaynak getirisi	-1.4%
Net Marj	-3.1%
Son Kazanç Güncellemesi	30 Sep 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Gelir ve Gider Dağılımı

Nureca nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

BSE:543264 Gelir, gider ve kazançlar (INR Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri
30 Sep 24	908	-28	184
30 Jun 24	910	6	179
31 Mar 24	919	-18	171
31 Dec 23	962	8	165
30 Sep 23	1,016	10	173
30 Jun 23	1,070	-48	192
31 Mar 23	1,113	-82	207
31 Dec 22	1,311	-81	287
30 Sep 22	1,514	-37	268
30 Jun 22	1,616	46	117
31 Mar 22	2,555	450	223
31 Dec 21	2,602	515	114
30 Sep 21	2,577	518	181
30 Jun 21	3,027	731	66
31 Mar 21	2,135	464	144
31 Mar 20	994	64	65
31 Mar 19	619	62	34
31 Mar 18	201	31	6
31 Mar 17	0	0	0

Kaliteli Kazançlar: 543264 şu anda kârlı değil.

Büyüyen Kar Marjı: 543264 şu anda kârlı değil.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 543264 kârlı değildir ve zararlar son 5 yılda yılda 68.2% oranında artmıştır.

Büyüme Hızlandırma: 543264 'un son bir yıldaki kazanç büyümesinin 5 yıllık ortalamasıyla karşılaştırılması mümkün değil çünkü şu anda kârlı değil

Kazançlar vs. Sektör: 543264 kârlı olmadığından, geçmiş yıl kazanç büyümesinin Medical Equipment sektörüyle ( 8.8% ) karşılaştırılması zorlaşıyor.

Özkaynak Getirisi

Yüksek ROE: 543264 hissesi şu anda kârlı olmadığından negatif Özsermaye Getirisi'ne ( -1.44% ) sahiptir.

Nureca Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

Second quarter 2025 earnings released: ₹0.48 loss per share (vs ₹2.90 profit in 2Q 2024)

Nureca Limited to Report Q2, 2025 Results on Oct 24, 2024

First quarter 2025 earnings released: EPS: ₹1.66 (vs ₹0.71 loss in 1Q 2024)

Nureca Limited to Report Q1, 2025 Results on Aug 05, 2024

Full year 2024 earnings released: ₹1.79 loss per share (vs ₹8.25 loss in FY 2023)

Full year 2024 earnings released: ₹1.79 loss per share (vs ₹8.25 loss in FY 2023)

Recent updates

Nureca Limited Announces Board Appointments, Effective January 1, 2025

Second quarter 2025 earnings released: ₹0.48 loss per share (vs ₹2.90 profit in 2Q 2024)

Nureca Limited to Report Q2, 2025 Results on Oct 24, 2024

First quarter 2025 earnings released: EPS: ₹1.66 (vs ₹0.71 loss in 1Q 2024)

Nureca Limited to Report Q1, 2025 Results on Aug 05, 2024

Full year 2024 earnings released: ₹1.79 loss per share (vs ₹8.25 loss in FY 2023)

Nureca Limited, Annual General Meeting, Jul 18, 2024

Full year 2024 earnings released: ₹1.79 loss per share (vs ₹8.25 loss in FY 2023)

Nureca Limited to Report Q4, 2024 Results on May 15, 2024

Third quarter 2024 earnings released: EPS: ₹0.16 (vs ₹0.30 in 3Q 2023)

Nureca Limited to Report Nine Months, 2024 Results on Feb 07, 2024

Nureca Limited Announces Naresh Gupta Announces CFO Changes

Second quarter 2024 earnings released: EPS: ₹2.90 (vs ₹2.89 loss in 2Q 2023)

Nureca Limited to Report Q2, 2024 Results on Nov 04, 2023

New minor risk - Share price stability

Nureca Limited Announces Resignation of Nishant Garg as Chief Financial Officer, Effective December 6, 2023

New major risk - Revenue and earnings growth

First quarter 2024 earnings released: ₹0.71 loss per share (vs ₹4.13 loss in 1Q 2023)

Nureca Limited to Report Q1, 2024 Results on Aug 10, 2023

Full year 2023 earnings released: ₹8.25 loss per share (vs ₹44.96 profit in FY 2022)

Nureca Limited, Annual General Meeting, Jul 20, 2023

Nureca Limited to Report Q4, 2023 Results on May 23, 2023

Third quarter 2023 earnings released: EPS: ₹0.30 (vs ₹1.67 in 3Q 2022)

Nureca Limited to Report Q3, 2023 Results on Feb 03, 2023

Nureca Limited Announces Resignation of Nitin R. Bidikar as an Independent Director

Second quarter 2023 earnings released: ₹2.89 loss per share (vs ₹5.43 profit in 2Q 2022)

High number of new and inexperienced directors

Second quarter 2023 earnings released: ₹2.89 loss per share (vs ₹5.43 profit in 2Q 2022)

Nureca Limited to Report Q2, 2023 Results on Nov 11, 2022

Nureca Approves Interim Dividend for Financial Year 2021-22

First quarter 2023 earnings released: ₹4.13 loss per share (vs ₹36.20 profit in 1Q 2022)

Nureca Limited to Report Q1, 2023 Results on Aug 12, 2022

Nureca Limited Approves Director Appointments

Full year 2022 earnings released: EPS: ₹44.96 (vs ₹62.04 in FY 2021)

Nureca Limited, Annual General Meeting, Jul 21, 2022

Nureca Limited to Report Q4, 2022 Results on May 28, 2022

High number of new and inexperienced directors

Nureca Limited Announces Resignation of Sushil Kumar Bhardwaj as Director, with Effect from February 28, 2022

Upcoming dividend of ₹3.00 per share

Nureca Limited Appoints Sushil Kumar Bhardwaj as Additional Director & Whole-Time Director of the Company Designated as Director - Compliance

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Director of Compliance & Additional Director Santosh Srivastava has left the company

Investor sentiment improved over the past week

Non-Executive Director Rajinder Sharma has left the company

First quarter 2022 earnings released: EPS ₹36.20 (vs ₹3.40 in 1Q 2021)

Investor sentiment improved over the past week

Chief Financial Officer Sakshi Mittal has left the company

Chief Financial Officer Sakshi Mittal has left the company

Full year 2021 earnings released: EPS ₹62.04 (vs ₹9.14 in FY 2020)

Investor sentiment improved over the past week

Gelir ve Gider Dağılımı

Kazanç ve Gelir Geçmişi

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Özkaynak Getirisi

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin